de Weerd AE - Search Results

1

Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series.

de Weerd AE, Roelen DL, Betjes MGH, Clahsen-van Groningen MC, Haasnoot GW, Kho MML, Reinders MEJ, Roodnat JI, Severs D, Karahan GE, van de Wetering J. de Weerd AE, et al. Transplant Direct. 2024 Aug 29;10(9):e1695. doi: 10.1097/TXD.0000000000001695. eCollection 2024 Sep. Transplant Direct. 2024. PMID: 39220218 Free PMC article.

2

Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts.

Betjes MGH, Sablik KS, Otten HG, Roelen DL, Claas FH, de Weerd A. Betjes MGH, et al. J Transplant. 2020 Jan 29;2020:5694670. doi: 10.1155/2020/5694670. eCollection 2020. J Transplant. 2020. PMID: 32099669 Free PMC article.

3

Imlifidase Desensitization in HLA-incompatible Kidney Transplantation: Finding the Sweet Spot.

de Weerd AE, Roelen DL, van de Wetering J, Betjes MGH, Heidt S, Reinders MEJ. de Weerd AE, et al. Transplantation. 2024 Feb 1;108(2):335-345. doi: 10.1097/TP.0000000000004689. Epub 2024 Jan 19. Transplantation. 2024. PMID: 37340532 Review.

4

The First Fifty ABO Blood Group Incompatible Kidney Transplantations: The Rotterdam Experience.

van Agteren M, Weimar W, de Weerd AE, Te Boekhorst PA, Ijzermans JN, van de Wetering J, Betjes MG. van Agteren M, et al. Among authors: de weerd ae. J Transplant. 2014;2014:913902. doi: 10.1155/2014/913902. Epub 2014 Feb 6. J Transplant. 2014. PMID: 24672705 Free PMC article.

5

ABO-Incompatible Kidney Transplant Outcomes: A Meta-Analysis.

de Weerd AE, Betjes MGH. de Weerd AE, et al. Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1234-1243. doi: 10.2215/CJN.00540118. Epub 2018 Jul 16. Clin J Am Soc Nephrol. 2018. PMID: 30012630 Free PMC article.

6

Alemtuzumab as Second-Line Treatment for Late Antibody-Mediated Rejection of Transplanted Kidneys.

Betjes MGH, Kho MML, Litjens NHR, de Weerd AE, Roodnat JI. Betjes MGH, et al. Among authors: de weerd ae. Transplant Proc. 2021 Sep;53(7):2206-2211. doi: 10.1016/j.transproceed.2021.07.005. Epub 2021 Aug 8. Transplant Proc. 2021. PMID: 34376313 Free article.

7

Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot Study.

de Weerd AE, Fatly ZA, Boer-Verschragen M, Kal-van Gestel JA, Roelen DL, Dieterich M, Betjes MGH. de Weerd AE, et al. Transpl Int. 2022 Oct 24;35:10839. doi: 10.3389/ti.2022.10839. eCollection 2022. Transpl Int. 2022. PMID: 36353052 Free PMC article. Clinical Trial.

8

RE: Imlifidase-generated Single-cleaved IgG: Implications for Transplantation.

de Weerd AE, Reinders MEJ, van de Wetering J, Roelen DL. de Weerd AE, et al. Transplantation. 2023 Jan 1;107(1):e36. doi: 10.1097/TP.0000000000004329. Epub 2022 Dec 8. Transplantation. 2023. PMID: 36508649 No abstract available.

9

Increasing Kidney-Exchange Options Within the Existing Living Donor Pool With CIAT: A Pilot Implementation Study.

de Klerk M, Kal-van Gestel JA, Roelen D, Betjes MGH, de Weerd AE, Reinders MEJ, van de Wetering J, Kho MML, Glorie K, Roodnat JI. de Klerk M, et al. Among authors: de weerd ae. Transpl Int. 2023 Jun 5;36:11112. doi: 10.3389/ti.2023.11112. eCollection 2023. Transpl Int. 2023. PMID: 37342179 Free PMC article.

10

Lowering maintenance immune suppression in elderly kidney transplant recipients; connecting the immunological and clinical dots.

Betjes MGH, De Weerd A. Betjes MGH, et al. Front Med (Lausanne). 2023 Jul 12;10:1215167. doi: 10.3389/fmed.2023.1215167. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37502354 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters